moderate anxiety
Conditions
Interventions
control group:Citalopram Hydrobromide Tablets
treatment group:Wendanningxin granule
Sponsors
Guang'anmen Hospital, Chian Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age: 18 ~ 65 years old, both male and female; (2) Conform to the diagnostic criteria of anxiety disorder in western medicine and the diagnostic criteria of heart and gall Qi deficiency syndrome; (3) At the time of enrollment, the total score of HAMA Anxiety Scale (17 items) was = 14 and = 29; (4) The total score of HAMD depression scale = 7 at the time of enrollment; (5) Informed consent and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with suicidal tendencies; (2) Severe anxiety (HAMA total score >29); (3) Anxiety attack secondary to other mental or physical diseases and accompanied by severe psychotic symptoms; (4) Patients with severe diseases of other systems and severe heart, liver and kidney dysfunction (including ALT and AST 1.5 times higher than normal); (5) Those who had taken anti anxiety agents within four weeks before enrollment; (6) Pregnancy or lactation or pregnancy; Women of childbearing age with positive urine pregnancy test; (7) Known alcoholics or drug addicts.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton Anxiety Scale;Self rating Anxiety Scale;Near infrared quantitative brain function imaging; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hamilton Depression Scale;Pittsburgh sleep quality index; | — |
Countries
China
Contacts
Public ContactYAN XUE
Guang'anmen Hospital, Chian Academy of Chinese Medical Sciences
Outcome results
None listed